+1 (202) 780-3397
IRON AND FOLIC ACID SUPPLEMENTATION USAGE IN THE PREGNANT WOMEN: A CROSS-SECTIONAL STUDY FOR RATIONAL DRUG USE
Joint Event on 7th International Conference and Exhibition on PHARMACOLOGY AND ETHNOPHARMACOLOGY & 5th GLOBAL PHYSIOTHERAPY, PHYSICAL REHABILITATION AND SPORTS MEDICINE
March 27-28, 2019 | Amsterdam, Netherlands
Halil Kara
Ankara Yildirim Beyazit University, Turkey
Scientific Tracks Abstracts : Asian J Biomed Pharmaceut Sci
Abstract:
Introductıon: Rational use of medicines is necessary in order to protect the human health and to provide
sustainable healthcare services in a qualified way. In a practical way, rational drug use especially in special
groups like pregnant and lactating women, elderly patients, newborns and children become more important.
Iron and folic acid deficiency are the most common health problems that may be seen in pregnancy and need
to be treated. Pharmacokinetics and pharmacodynamics of drugs may be changed due to the physiological
changes in pregnancy. Iron and folic acid requirement enhances due to the increased consumption during
pregnancy. Weakness and fatigue may be occurred due to the insufficient oxygenation of the tissues in the
mother because of the iron and the folic acid deficiency in pregnancy. Developmental failure, abortion and
neural tube defects may be also occurred in the infants. The aim of this study was to determine iron and folic
acid prescription rate in pregnant women and the attitudes of pregnant women in case of adverse reactions in
the meaning of principles of rational drug use.
Materıals & Methods: We conducted a survey to the pregnant women and defined them by age into groups
as 20-24, 25-29, 30-34 and 35-39 (20 patients each) in our hospital. Our survey also reflected demographic
information, including age, education, number of pregnancies and gestational week. In addition, the survey
also includes the questions about the prescription rate of iron and folic acid and whether these are used in accordance
with the doctor’s recommendation, and the questions about the attitudes and behaviors of pregnant
women in the occurrence of adverse effects.
Conclusıon: As in all over the world, iron and folic acid levels are measured for individuals who applied to the
hospital due to pregnancy; replacement therapy is given to those who have a deficiency. In our study, we determined
that the rate of initiation of iron and folic acid treatment increased as pregnancy age and number of
pregnancies increased. As a result of increase in ages and the number of pregnancies, naturally, iron and folic
acid depots are emptied. For healthy pregnancy externally supplementation is necessary. We found that using
of iron and folic acid supplementation in pregnant women was according to prescription of their physician. In
the event of an adverse effect or where an unexpected effect occurs due to the drug, we have determined that
all of our subjects will decide to respond by contacting their physicians. In conclusion, we found that the use of
iron and folic acid by pregnant women was in accordance with the principles of rational drug use.
Biography:
Halil Kara graduated from Gazi University as faculty of medicine and completed his PhD in medical pharmacology at Gazi University. He worked as a manager at Gazi University Health Center, assistant manager in Ankara Provincial Health Directorate and head of department at Turkish Republic Ministry of Health. He is still working on his projects and giving lectures to both graduate and undergraduate students. He has been serving as the President of the clinical research ethics committee since 2013.
E-mail: drhalilkara@gmail.com
PDF HTML